These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Design and biological evaluation of novel triaryl pyrazoline derivatives with dioxane moiety for selective BRAF Li HL; Su MM; Xu YJ; Xu C; Yang YS; Zhu HL Eur J Med Chem; 2018 Jul; 155():725-735. PubMed ID: 29940463 [TBL] [Abstract][Full Text] [Related]
9. Structural basis for the recognition of Asef by adenomatous polyposis coli. Zhang Z; Chen L; Gao L; Lin K; Zhu L; Lu Y; Shi X; Gao Y; Zhou J; Xu P; Zhang J; Wu G Cell Res; 2012 Feb; 22(2):372-86. PubMed ID: 21788986 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach. Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors. Qin YJ; Li YJ; Jiang AQ; Yang MR; Zhu QZ; Dong H; Zhu HL Eur J Med Chem; 2015 Apr; 94():447-57. PubMed ID: 25828827 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation, and in silico study of pyrazoline-conjugated 2,4-dimethyl-1H-pyrrole-3-carboxylic acid derivatives. Rasal NK; Sonawane RB; Jagtap SV Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000267. PubMed ID: 33078449 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and Biological Evaluation of 1-Methyl-1H-indole-Pyrazoline Hybrids as Potential Tubulin Polymerization Inhibitors. Zhang YL; Qin YJ; Tang DJ; Yang MR; Li BY; Wang YT; Cai HY; Wang BZ; Zhu HL ChemMedChem; 2016 Jul; 11(13):1446-58. PubMed ID: 27159418 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents. Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290 [TBL] [Abstract][Full Text] [Related]
15. Modification, Biological Evaluation and SAR Studies of Novel 1H-Pyrazol Derivatives Containing N,N'-Disubstituted Urea Moiety as Potential Anti-melanoma Agents. Ruan BF; Lin MX; Shao Q; Wang TH; Zhang Q; Dong YL; Bu CN; Xu HJ; Zhou BG; Li QS Chem Biodivers; 2018 Jun; 15(6):e1700504. PubMed ID: 29687639 [TBL] [Abstract][Full Text] [Related]
16. Discovery of novel HSP90 inhibitors that induced apoptosis and impaired autophagic flux in A549 lung cancer cells. Wei Q; Ning JY; Dai X; Gao YD; Su L; Zhao BX; Miao JY Eur J Med Chem; 2018 Feb; 145():551-558. PubMed ID: 29339250 [TBL] [Abstract][Full Text] [Related]
17. Design and efficient synthesis of pyrazoline and isoxazole bridged indole C-glycoside hybrids as potential anticancer agents. Kumari P; Mishra VS; Narayana C; Khanna A; Chakrabarty A; Sagar R Sci Rep; 2020 Apr; 10(1):6660. PubMed ID: 32313038 [TBL] [Abstract][Full Text] [Related]
18. 1-Phenyl-1H-indole derivatives as a new class of Bcl-2/Mcl-1 dual inhibitors: Design, synthesis, and preliminary biological evaluation. Xu G; Liu T; Zhou Y; Yang X; Fang H Bioorg Med Chem; 2017 Oct; 25(20):5548-5556. PubMed ID: 28866374 [TBL] [Abstract][Full Text] [Related]
19. Novel nicotinoyl pyrazoline derivates bearing N-methyl indole moiety as antitumor agents: Design, synthesis and evaluation. Chen K; Zhang YL; Fan J; Ma X; Qin YJ; Zhu HL Eur J Med Chem; 2018 Aug; 156():722-737. PubMed ID: 30041136 [TBL] [Abstract][Full Text] [Related]
20. Discovery and evaluation of 3,5-disubstituted indole derivatives as Pim kinase inhibitors. More KN; Hong VS; Lee A; Park J; Kim S; Lee J Bioorg Med Chem Lett; 2018 Aug; 28(14):2513-2517. PubMed ID: 29871845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]